Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ·Healthcare·Biotechnology
$1.67
-1.48%
Mkt Cap $711.78M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 5, 2026 | $3.14M | $5.49M | +74.85% | -$0.07 | -$0.04 | +42.86% | — | — |
| Q4 2025 Nov 6, 2025 | $3.14M | $14.18M | +351.43% | -$0.07 | -$0.04 | +42.86% | — | — |
| Q3 2025 Aug 6, 2025 | $5.81M | $28.87M | +396.71% | -$0.08 | $0.01 | +112.50% | — | — |
| Q2 2025 May 13, 2025 | $1.31M | $1.26M | -3.42% | -$0.10 | -$0.07 | +30.00% | — | — |
| Q1 2025 Mar 6, 2025 | $2.82M | $26.55M | +842.63% | -$0.11 | -$0.09 | +18.18% | — | — |
| Q4 2024 Nov 12, 2024 | $6.48M | $1.75M | -72.99% | -$0.17 | -$0.18 | -5.88% | — | — |
| Q3 2024 Aug 1, 2024 | $8.16M | $1.65M | -79.82% | -$0.18 | -$0.17 | +5.56% | — | — |
| Q2 2024 May 2, 2024 | $1.40M | $1.13M | -19.29% | -$0.18 | -$0.20 | -11.11% | — | — |
| Q1 2024 Mar 11, 2024 | $1.24M | $702.00K | -43.39% | -$0.23 | -$0.20 | +13.04% | — | — |
| Q4 2023 Nov 8, 2023 | $4.79M | $162.00K | -96.62% | -$0.22 | -$0.21 | +4.55% | — | — |
| Q3 2023 Aug 3, 2023 | $4.06M | $317.00K | -92.19% | -$0.17 | -$0.22 | -29.41% | — | — |
| Q2 2023 May 2, 2023 | $30.00K | $24.00K | -20.00% | -$0.17 | -$0.17 | +0.00% | — | — |
| Q1 2023 Mar 2, 2023 | $50.00K | $28.00K | -44.00% | -$0.14 | -$0.16 | -14.29% | — | — |
| Q4 2022 Nov 9, 2022 | $50.00K | $39.00K | -22.00% | -$0.15 | -$0.13 | +13.33% | — | — |
| Q3 2022 Aug 2, 2022 | $100.00K | $35.00K | -65.00% | -$0.15 | -$0.16 | -6.67% | — | — |
| Q2 2022 May 5, 2022 | $50.00K | $37.00K | -26.00% | -$0.16 | -$0.16 | +0.00% | — | — |
| Q1 2022 Feb 28, 2022 | $14.78K | $14.00K | -5.26% | -$0.17 | -$0.17 | +0.00% | — | — |
| Q4 2021 Nov 3, 2021 | $120.00K | $23.00K | -80.83% | -$0.18 | -$0.16 | +11.11% | — | — |
| Q3 2021 Jul 30, 2021 | $10.00K | $234.00K | +2240.00% | -$0.16 | -$0.13 | +18.75% | — | — |
| Q2 2021 May 6, 2021 | $110.00K | $27.00K | -75.45% | -$0.17 | -$0.15 | +11.76% | — | — |